Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

668 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 668 results

Large-scale testing (Phase 3)Study completedNCT01349283
What this trial is testing

Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns

Who this might be right for
Hepatitis B
Crucell Holland BV 1,738
Large-scale testing (Phase 3)Study completedNCT05321394
What this trial is testing

Non-inferiority Trial on Treatments in Early COVID-19

Who this might be right for
COVID-19
Azienda Ospedaliera Universitaria Integrata Verona 536
Post-approval studies (Phase 4)Study completedNCT02798952
What this trial is testing

Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

Who this might be right for
Hepatitis B
GlaxoSmithKline 302
Large-scale testing (Phase 3)Ended earlyNCT05205759
What this trial is testing

Non-inferiority Trial on Monoclonal Antibodies in COVID-19

Who this might be right for
COVID-19
Azienda Ospedaliera Universitaria Integrata Verona 319
Testing effectiveness (Phase 2)UnknownNCT04396067
What this trial is testing

Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Who this might be right for
COVID-19
Kafrelsheikh University 360
Not applicableWithdrawnNCT04418531
What this trial is testing

Convalescent Antibodies Infusion in COVID 19 Patients

Who this might be right for
Pneumonia, ViralCorona Virus Infection
Piero Luigi Ruggenenti
Testing effectiveness (Phase 2)Study completedNCT00001475
What this trial is testing

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 85
Not applicableLooking for participantsNCT07089836
What this trial is testing

This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.

Who this might be right for
Treponema PallidumTreponema Pallidum InfectionSyphilis Infection+4 more
American Laboratory Products Company 1,000
Early research (Phase 1)Study completedNCT02411539
What this trial is testing

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT02355951
What this trial is testing

Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection

Who this might be right for
Chronic Hepatitis B
Transgene 166
Testing effectiveness (Phase 2)Ended earlyNCT04432272
What this trial is testing

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus Infections
Corewell Health East 71
Early research (Phase 1)Not Yet RecruitingNCT07377253
What this trial is testing

First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.

Who this might be right for
The Tick-borne Encephalitis Virus (TBEV)
Giuseppe Pantaleo 18
Not applicableUnknownNCT04348877
What this trial is testing

Plasma Rich Antibodies From Recovered Patients From COVID19

Who this might be right for
Coronavirus Disease (COVID-19)
Ain Shams University 20
Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Not applicableLooking for participantsNCT06968442
What this trial is testing

The Role of Obesity in Severe COVID-19 Pathophysiology

Who this might be right for
COVID-19Antibody COVID-19
Franciscus Gasthuis 60
Early research (Phase 1)Study completedNCT04773665
What this trial is testing

Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

Who this might be right for
Covid19
VBI Vaccines Inc. 114
Post-approval studies (Phase 4)Study completedNCT01037114
What this trial is testing

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Who this might be right for
Hepatitis AHepatitis B
GlaxoSmithKline 50
Not applicableStudy completedNCT04871945
What this trial is testing

Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

Who this might be right for
Covid19Vaccine ReactionHemolysis+1 more
Hanyang University Seoul Hospital 31
Testing effectiveness (Phase 2)Ended earlyNCT01121185
What this trial is testing

Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

Who this might be right for
HCV InfectionLiver Transplantation
MassBiologics 13
Not applicableStudy completedNCT00006298
What this trial is testing

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 125
Load More Results